In a significant regulatory update, fertility clinics and sperm banks are now required to register under the ART and Surrogacy Acts to access necessary IVF laboratory materials. The Central Drugs Standard Control Organisation (CDSCO) has issued this guideline to prevent unregistered entities from gaining access to critical supplies like IVF media and reagents, which could pose risks to patient health.